Navigation Links
Free Medicines, Health Insurance for Poor Soon: Paswan

is yet to be taken.

With the government announcing plans of raising the budgetary allocation for the health sector from 0.9 percent of GDP to 2-3 percent, Paswan said the additional resources would make it possible to offer health insurance to the poor in rural and urban areas.

"In addition to the proposed hike in health allocation, there is the Prime Minister's Relief Fund, the Health Minister's Relief Fund and other contingency funds that can be utilised to provide facilities for the poor," said Paswan.

Another important step proposed by the ministry is offering free or subsidised medication for critical illnesses like cancer and HIV/AIDS.

"The policy will address the need to provide subsidised drugs for critical or life-threatening diseases that require expensive treatment. In the case of BPL population, we hope to offer free medication. But for those above poverty line (APL), (we will) provide drugs at 50 percent subsidised rates," Paswan added.

The innovative step may introduce a new model of drug purchase by state-run hospitals.

"We have proposed that government hospitals procure medicines for treatment of cancer, HIV/AIDS, tuberculosis and other critical illness directly from the manufactures and thereby eliminate the 15 percent wholesaler and 35 percent retailer margin," said Paswan.

"This is an achievable goal as we have closely studied the Rajasthan formula, which has succeeded in providing cheaper medicines to patients," he said.

The inspiration behind this is the state-run Rajasthan Medicare Relief Society that directly procures medicines from manufacturers and sells to patients with a limited mark-up price.

Source-IANS
'"/>




Page: 1 2

Related medicine news :

1. Startling Expose – Physicians Often Have No Regular Source Of Health Car
2. Want a Healthy brew? Have some Tea!
3. Healthcare sector is now a multi billion-dollar industry in India
4. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
5. Health at heights
6. Health Officials Recommend Flu Vaccine
7. Slightly High BP Poses Health Risk
8. Unsatisfactory Grade On Womens Health Issues
9. Iodex goes to SmithKline Beecham consumer Healthcare
10. Healthy Medicine Or Harmful Intoxicant?
11. Healthy snacks improve nutrition of kids
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...rcises can help restore erectile function in men, ...the University of the West of England in Bristol f...floor exercises had the same overall improvement a...elvic floor is made up of layers of muscle and oth...
...ered a gene mutation that may cause premature ovar...be useful for further study into, what researchers...ovarian failure is a form of infertility that affe...es. It is diagnosed in one out of every 100 women ...
...d allergy -- especially to peanuts -- has been sho...in children. Asthma attacks are the most common re...am Roberts from St. Mary's Hospital in London and ...n treatment, death due to childhood asthma has not...
...lacement therapy dosed to normalize IGF-I levels m...on in a "clinically necessary" weight loss program...ograms is to lose body fat but retain lean body ma... when people go on a diet, after a while, they sto...
Other Medicine News:Health News:Low-dose Growth Hormone (GH) with diet and exercise may help weight loss 2
(Date:10/8/2008)...Review Zanolimumab Program to be Discontinued and ... the Results of its Portfolio Review; Zanolimumab ...educe the Number of ...tCall/ -- Genmab A/S (OMX: GEN),announced today th...(HuMax-CD4(R)). In addition, as a result of a port...
(Date:10/8/2008)... -- Exploratory study shows clinical improvement...sion (PAH), -- Current treatment options have l... progressive and incurable blood vessel disease, ...r treatment of certain cancers, known to inhi... further explore potential of imatinib mesylate in...
(Date:10/7/2008)... Results of FLEXX Trial Presented at the Osteoar...d Congress, PARSIPPANY, N.J., Oct. 7 /PRNewswire/...d results from the FLEXX Trial of Osteoarthritis o...aluronate), a highly pure,non-avian high molecular...A-HA), is superior to intra-articular saline (IA-s...
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A s...amining embryonic stem cell self-renewal,reported...stim (recombinant,human serum albumin) was an effe...ll culture., The article entitled, "The ground st...d that researchers used Cellastim as a recombinant...
Breaking Medicine Technology:Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4RAND study finds increase in piracy and terrorism at sea 3536 1RAND study finds increase in piracy and terrorism at sea 3536 2RAND study finds increase in piracy and terrorism at sea 3536 3Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 1Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 2Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 3Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 4Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 1Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 2Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 3Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 4Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 5SC Magazine 3A Entrust Entelligence Messaging Server Earns Five Stars and Recommended Rating 3533 1SC Magazine 3A Entrust Entelligence Messaging Server Earns Five Stars and Recommended Rating 3533 2SC Magazine 3A Entrust Entelligence Messaging Server Earns Five Stars and Recommended Rating 3533 3
...CO, Calif., April 03, 2007,/PRNewswire-FirstCall/ ...ed results from its second multi-center Phase 2 tr...h evaluated escalating doses,of the immunotherapy ...prostate cancer (HRPC). Additional follow-up of,th...able to that,being employed in the company,s ongoi...
...(BUSINESS WIRE)--Apr 3, 2007 - Arrowhead Research,...on by its,majority-owned subsidiary Calando Pharma...proliferative effect of the siRNA sequence,selecte...ncer,compound, CALAA-01., The paper, entitled "Pot...ubunit RRM2 Reduce Cell Proliferation In vitro and...
Other Medicine Technology:Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
Heavy. 7.5 mm curved tip.
Delicate Desmarres lid retractors, round serrated handle, very thin blades, polished finish, size 1.
Size 4 - 2.25 mm
The Catalyst system introduces a new level of computer enhanced precision to microsurgical instrumentation. It has an easy to use digital design with advanced microcomputer control of modules and is
Medicine Products: